FDA Reopens Comment Period for Draft Guidance on Medical Product Promotion

Summary

The Food and Drug Administration (FDA) is extending the comment period for a draft guidance on promoting medical products in a changing healthcare environment until July 31, 1998, to allow interested parties more time to prepare and submit comments.